Clinical Evidence and GLP-1 Sourcing Considerations GLP-1 medicationswhether semaglutide, tirzepatide, or emerging compoundshave demonstrated clinical efficacy in randomized trials (STEP trials for semaglutide
The American Diabetes Association recommends A1C testing every three months for patients not at goal or after therapy changes, and at least twice yearly for those meeting targets
It is an easy and pain-free method of taking medication
Final Thoughts GLP-1s are powerful tools that mimic a hormone your body already makesbut how you use them matters
They're marketed as a convenient alternative to "pills, powders and needles" pop one on your arm in the morning, get on with your day, and supposedly the active ingredients are absorbed through your skin
Their ability to keep you feeling full longer can also be beneficial for weight management